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Genetic suppression of phenotypes arising from mutations in
dystrophin-related genes in Caenorhabditis elegans
Kathrin Gieseler, Karine Grisoni and Laurent Ségalat
Background: Dystrophin is the product of the gene that is mutated in
Duchenne muscular dystrophy (DMD), a progressive neuromuscular disease for
which no treatment is available. Mice carrying a mutation in the gene for
dystrophin (mdx mice) display only a mild phenotype, but it is aggravated when
combined with a mutation in the MyoD gene. The nematode worm
Caenorhabditis elegans has a dystrophin homologue (dys-1), but null mutations
in dys-1 do not result in muscle degeneration.
Results: We generated worms carrying both the dys-1 null mutation cx18, and
a weak mutation, cc561ts, of the C. elegans MyoD homologue hlh-1. The
double mutants displayed a time-dependent impairment of locomotion and egg
laying, a phenotype not seen in the single mutants, and extensive muscle
degeneration. This result allowed us to look for genes that, when misexpressed,
could suppress the dys-1; hlh-1 phenotype. When overexpressed, the dyc-1
gene — whose loss-of-function phenotype resembles that of dys-1 — partially
suppressed the dys-1; hlh-1 phenotype. The dyc-1 gene encodes a novel
protein sharing similarities with the mammalian neural nitric oxide synthase
(nNOS)-binding protein CAPON, and is expressed in the muscles of the worm. 
Conclusions: As a C. elegans model for dystrophin-dependent myopathy, the
dys-1; hlh-1 worms should permit the identification of genes, and ultimately
drugs, that would reverse the muscle degeneration in this model.
Background
Dystrophin is the product of the gene that is mutated in
Duchenne and Becker muscular dystrophies (DMD and
BMD), two progressive neuromuscular diseases affecting
approximately 1 in 3,500 male births [1]. Dystrophin is a
3,685 amino acid protein found in skeletal and cardiac
muscles [2]. Shorter forms of the protein are generated by
internal promoters [3]. Dystrophin is located under the
sarcolemma, bound by its amino-terminal end to actin fila-
ments, and by its carboxy-terminal end to a transmembrane
complex of glycoproteins (DGC) [3]. As α-dystroglycan, an
extracellular component of the DGC, binds the extracellu-
lar matrix (ECM), it is considered that dystrophin and the
DGC form a link between the ECM and the cytoskeleton
[3–5]. Despite extensive biochemical and cellular character-
isation, the function of this link is still poorly understood.
Moreover, the mechanism of the muscle degeneration
observed in DMD patients is not yet known.
In mammals, utrophin, a ubiquitously expressed protein
very similar to dystrophin, is partly redundant with dys-
trophin [6]. A third dystrophin-like protein, DRP2, is
expressed only in the nervous system [7]. Mice carrying a
mutation in the dystrophin gene (mdx mice) display only a
mild myopathy [8], indicating that humans and mice do
not compensate similarly for the absence of dystrophin.
Mice carrying mutations in both the dystrophin and
utrophin genes have severe myopathies [9,10], but the rele-
vance of this model to DMD is uncertain. The canine model
of DMD, known as golden retriever muscular dystrophy
(GRMD), is much closer to the human pathology [11], but
for ethical reasons cannot be used extensively in research.
Invertebrates possess only one dystrophin-like gene [12].
The presence of a dystrophin homologue in the genome
of genetically tractable animals such as the nematode
worm Caenorhabditis elegans or the fruit fly Drosophila
offers an opportunity to tackle the question of dystrophin
function by forward genetics, an approach which has
proven promising for other human pathologies [13,14].
The advantage of this approach is the ability to address a
biological question without any prior knowledge of the
genes and proteins involved. We have undertaken an
analysis of dystrophin function in C. elegans. Worms carry-
ing putative null mutations of the dystrophin-like gene
dys-1 display a specific but subtle behavioral defect con-
sisting of hyperactive locomotion, exaggerated bending of
the head, and a tendency to hypercontract [15]. They
show no sign of muscle degeneration [15]. The lack of
muscle degeneration in dys-1 animals can be explained by
the short lifespan of the animals, as the phenotypes take
weeks to appear in mammals [15].
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In this paper, we report that placing the dys-1 mutation in
a weak hlh-1 genetic background leads to a time-depen-
dent muscle degeneration. We also report the cloning of
dyc-1, a novel gene for which loss-of-function mutations
resemble that of dys-1. Overexpression of dyc-1 resulted
in partial suppression of the degeneration phenotype of
dys-1; hlh-1 animals.
Results
Progressive myopathy in dys-1(cx18); hlh-1(cc561ts)
double mutants
As mice lacking both dystrophin and the myogenic factor
MyoD display severe myopathy, compared with mdx mice
[16], we tested the effect of combining the analogous
mutations in C. elegans. The C. elegans homologue of the
MyoD gene is the hlh-1 gene, of which null alleles are
lethal [17,18]. In this study, we used the thermosensitive
allele hlh-1(cc561ts), which is a hypomorphic allele of hlh-1
viable at 15°C [19], and dys-1(cx18), which is a putative
null allele of dys-1, as its phenotype cannot be distin-
guished from carboxy-terminal deletions of the gene [15].
At 15°C, hlh-1(cc561ts) worms appeared wild type and
showed normal locomotion, except for a small fraction
(5–10%), which were born as short, dumpy animals. The
dys-1(cx18) worms were slightly hyperactive, but, like
hlh-1(cc561ts) worms, left regular wave-like tracks on the
plate. The dys-1(cx18); hlh-1(cc561ts) double mutant, in
contrast, displayed a progressive impairment of locomo-
tion at adult stages (Table 1, Figures 1,2). At day 7,
approximately 2 days after adulthood began, 100% of the
animals had become strongly uncoordinated (Figure 1).
These animals moved slowly and left irregular tracks on
the plate (Figure 2). In addition, the double mutant was
egg-laying defective, a phenotype not seen in the single
mutants (Table 1). We verified that this phenotype was
due to a synergistic effect of the mutations, and not due to
a hidden background mutation. The presence of a trans-
gene containing the wild-type genes hlh-1 [19] (Figure 1)
or dys-1 (data not shown) in the double mutant restored
locomotion and egg-laying behaviour to the level observed
in the single mutants. 
We observed the musculature of the mutants by staining
animals with the filamentous actin (F-actin) marker phal-
loidin, which reveals the sarcomeric organisation of the
striated body wall muscles [20]. Most body wall muscles
of dys-1(cx18) and hlh-1(cc561ts) animals had a wild-type
pattern consisting of a regular arrangement of striated
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Table 1
Phenotypes of dys-1; hlh-1 double mutants and animals overexpressing dyc-1.
Genotype Percentage of Number of Number of 
uncoordinated animals eggs in utero abnormal muscle cells
Wild type N2 0 ± 0 10.2 ± 1.6 0 ± 0
dys-1(cx18) 0 ± 0 7.5 ± 2.9 0 ± 0
hlh-1(cc561ts) 7 ± 2 14.0 ± 3.5 1.5 ± 1.5
dys-1(cx18); hlh-1(cc561ts) 82 ± 5 24.1 ± 5 13.9 ± 4.5
dys-1(cx18)Ex(dyc-1); hlh-1(cc561ts) 45 ± 4* 8.7 ± 5* 7.2 ± 2.5*
The synergistic effect of the mutations dys-1(cx18) and hlh-1(cc561ts)
led to disorganisation of the musculature of the double mutant,
resulting in uncoordinated locomotion and egg-laying defects in adults.
In dys-1(cx18)Ex(dyc-1); hlh-1(cc561ts) worms, which overexpress
the dyc-1 gene, these phenotypes were partially reversed. The dyc-1
gene encodes a protein related to CAPON. All strains were grown at
15°C. Adults were scored 48 h after the L4 stage, which is
approximately day 6 after eggs were laid. Uncoordination is defined as
failure to produce three consecutive sinusoidal body waves. Only 40
muscle cells were assessed for each animal (see Materials and
methods for details). Data are given as ± SD. *Statistically different
from the data for dys-1(cx18); hlh-1(cc561ts), p < 0.01.
Figure 1
The dys-1; hlh-1 double mutants become progressively uncoordinated.
The dys-1(cx18) worms (filled circles) were not uncoordinated;
hlh-1(cc561ts) worms (empty circles) were also not uncoordinated
except for a small proportion that did not elongate properly and hatched
as short, dumpy worms. The dys-1(cx18); hlh-1(cc561ts) double
mutants showed normal locomotion as larvae but became
uncoordinated as adults (filled squares). This phenotype was reverted in
double mutants carrying a wild-type hlh-1 transgene (empty squares).
The horizontal axis shows the number of days after eggs were laid.
Adulthood begins at day 5 (strains grown at 15°C). Uncoordination is
defined as failure to produce three consecutive sinusoidal body waves.
More than 100 animals were scored for each data point. 
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diamond-shaped cells (Figure 3a–c). In dys-1(cx18);
hlh-1(cc561ts) adults, however, the body wall muscles were
severely disorganised, with up to 50% of the cells display-
ing an abnormal F-actin pattern or no pattern at all
(Figure 3d,e). The alteration of the musculature accounts
for the locomotory defects of the dys-1(cx18); hlh-1(cc561ts)
animals. The alteration of the muscle F-actin pattern was
less frequent in larval stages (Figure 4). It correlated with
the progressive onset of defective locomotion.
The dys-1(cx18); hlh-1(cc561ts) phenotype is partly
suppressed by dyc-1 overexpression
We then searched for genes that could suppress or reduce
the phenotype of dys-1(cx18); hlh-1(cc561ts). The gene dyc-1
(for dystrophin-like phenotype and Capon-related) was a
good candidate because it belongs to a group of C. elegans
genes that we isolated in forward-genetic screens on the
basis of their recessive dys-1-like phenotype (L.S., unpub-
lished results). As dys-1 and members of this group share
similar phenotypes, and double mutants between members
of this group and dys-1 resemble dys-1 animals, it is likely
that these genes participate in a common cellular function.
Therefore, we tested whether overexpression of dyc-1
could compensate for the absence of dys-1 function, that
is, could suppress or reduce the phenotype of dys-1(cx18);
hlh-1(cc561ts) animals. Overexpression of dyc-1 partially
reduced the locomotion and egg-laying defects of
dys-1(cx18); hlh-1(cc561ts) worms (Table 1, Figure 2). The
proportion of abnormal muscles was also reduced in the
animals overexpressing dyc-1 (Table 1 and Figure 3f).
The dyc-1 gene encodes a novel muscular protein with
similarities to CAPON
The dyc-1 gene was cloned by positional cloning. It was
found to map between the markers unc-9 and unc-3 on the
genetic map and to correspond to the predicted gene
C33G3.1 (see Materials and methods). The dyc-1 gene
encodes a novel protein that has no known homologues in
the public sequence databases. We found two regions in
the DYC-1 protein with similarity to the rat CAPON
protein, which has been identified as a neural nitric oxide
synthase (nNOS)-binding protein in a yeast two-hybrid
screen [21] (Figure 5). DYC-1 is the closest C. elegans rela-
tive to CAPON. Within the CAPON-like region of DYC-1,
we found a repetition of leucines separated by six amino
acids, a motif reminiscent of coiled-coil domains (amino
acids 388–412). We assayed dyc-1 expression by reporter
gene analysis. For this purpose, we generated DNA con-
structs consisting of 4 kb of dyc-1 5′ sequences introduced
upstream of sequences encoding the green fluorescent
protein (GFP) [22], and injected the constructs into wild-
type animals. Transgenic animals expressing DYC-1–GFP
showed consistent GFP expression in the head muscles,
the body wall muscles, and the vulva muscles (Figure 6).
Weaker expression in the intestinal muscles was also
Figure 2
Locomotory behaviour of dys-1; hlh-1 double mutants and animals
overexpressing dyc-1. Tracks of (a) wild-type, (b) hlh-1(cc561ts),
(c) dys-1(cx18), (d) dys-1(cx18); hlh-1(cc561ts), and
(e) dys-1(cx18); hlh-1(cc561ts)Ex(dyc-1) adult animals. The irregular
pattern formed by (d) dys-1(cx18); hlh-1(cc561ts) was partly
corrected in (e). Animals were put on plates 48 h after the L4 stage.
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Figure 3
Muscle structure abnormalities in dys-1; hlh-1
double mutants and animals overexpressing
dyc-1. Fluorescence microscopy of phalloidin-
stained (a) wild-type, (b) dys-1(cx18),
(c) hlh-1(cc561ts), (d,e) dys-1(cx18);
hlh-1(cc561ts), and (f) dys-1(cx18);
hlh-1(cc561ts)Ex(dyc-1) adults. One body
wall muscle quadrant is visible on each panel.
In (a), muscle cells in each quadrant appear
as a regular arrangement of striated diamond-
shaped structures (black arrow). This
arrangement was severely perturbed in
(d,e) dys-1(cx18); hlh-1(cc561ts) animals;
many cells were absent or had an abnormal
pattern (white arrows). (f) A more regular
structure was observed in animals
overexpressing dyc-1 (black arrows).
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detected in some animals (data not shown). No GFP
expression was observed in the pharyngeal muscles nor in
non-muscle cells.
Discussion
We have shown that introducing a putative null allele of
the C. elegans dys-1 gene in the hlh-1(cc561ts) genetic back-
ground results in a progressive and severe alteration of the
musculature. Numerous mutations have been isolated in
C. elegans that affect muscle structure or function (or both)
[23,24]. Most of these mutations affect larvae as well as
adults. It is of particular interest that the phenotype of
dys-1(cx18); hlh-1(cc561ts) is time dependent, a trait charac-
teristic of the related disease DMD. This observation is
consistent with previous results supporting the hypothesis
that the DYS-1 protein and its mammalian counterparts
share conserved functions [15]. In mice, the increased
severity of the MyoD; mdx mutation, compared with the
mdx mutation alone, is thought to be caused by a reduc-
tion of the muscle’s ability to regenerate from satellite
cells, thereby disrupting the equilibrium of degeneration
and regeneration that occurs in mdx mice [16]. C. elegans
muscles differ from mammalian ones in that they do not
contain satellite cells [23]. Therefore, damaged muscle
cells are not replaced in C. elegans, leading to the progres-
sive phenotype that we observed. Like its mammalian
counterparts of the MyoD family, the hlh-1 gene is required
for proper myogenesis. In the absence of the hlh-1
product, which is normally present in mature cells and
their precursors, C. elegans body wall muscles form but
do not contract properly [18]. The mild hlh-1(cc561ts)
mutation has, however, no visible effect on body wall
muscles when animals are grown at 15°C [19]. The mech-
anism underlying the progressive degeneration of the
musculature observed in C. elegans dys-1(cx18); hlh-1(cc561ts)
mutants is unknown at this point.
Genes involved in a common biological function often
produce similar phenotypes when mutated. Based on this
idea, we isolated dys-1-like recessive mutations in several
genes. One of them (dyb-1) has previously been identified
as a homologue of dystrobrevin, a dystrophin-binding
protein [25]. We have now reported the cloning of dyc-1, a
new member of this class. Recessive mutations of dyc-1
are indistinguishable from dys-1 alleles. The dyc-1 gene
has no known homologue, but contains two regions of
similarity with the nNOS-binding protein CAPON.
Although nitric oxide has been reported to exist as a neu-
romediator in Ascaris nematodes [26], the C. elegans
genome does not seem to contain a nNOS homologue
(L.S., unpublished results). It is nevertheless intriguing
that we have identified a CAPON-related protein in a
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Figure 4
The muscular phenotype of dys-1; hlh-1 is time dependent. Bars
indicate the percentage of body wall muscle cells showing an
abnormal F-actin pattern. Error bars indicate the standard deviation.
Animals were grown at 15°C and stained with phalloidin–rhodamine.
Adults were analysed 48 h after the L4 stage. More than 30 animals
were scored for each data point.
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Figure 5
Structure of the dyc-1 gene. Top, schematic representation of the
X chromosome of C. elegans (genetic map). The dyc-1 gene is located
between the unc-9 and unc-3 phenotypic markers. Numbers indicate
genetic map coordinates. Middle, representation of the C33G3
cosmid and the deletions used to map the dyc-1 gene on C33G3.
Bottom, genomic organisation of the dyc-1 gene. Boxes, exons; lines,
introns; unshaded boxes, coding sequences; shaded boxes, the 5′ and
3′ untranslated regions. The amino-acid sequence of regions with
similarity to CAPON are shown below. Residues that are identical in
the two proteins are indicated in bold.
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forward-genetic screen for genes functionally related to
dystrophin. In mammals, nNOS is associated with the
dystrophin complex, and alterations of this complex lead
to a mislocalisation of nNOS [27]. CAPON has been
shown to compete with PSD95 for interaction with nNOS
[21], but its in vivo function remains elusive. The fact
that a dyc-1 loss-of-function mutant exhibits a dys-1-like
phenotype, and that dyc-1 overexpression partially sup-
presses dys-1(cx18); hlh-1(cc561ts) phenotypes indicate
that dys-1 and dyc-1 participate in a common muscular
function. In the absence of a strong gain-of-function phe-
notype of either dys-1 or dyc-1, we cannot perform epista-
sis tests to place the two genes on a putative pathway.
The fact that the dys-1(cx18); hlh-1(cc561ts) phenotype is
only partially suppressed by dyc-1 overexpression rules
out the possibility that dyc-1 is a unique downstream
effector of dys-1 function in C. elegans. Transposed to the
mammalian context, our results raise the possibility that
CAPON or CAPON-like proteins may antagonise dys-
trophin-related muscle degeneration, and hence be a pos-
sible therapeutic target for DMD treatment. 
Conclusions
We have created a C. elegans model of dystrophin-dependent
progressive myopathy that will allow systematic screens for
gene mutations that revert this phenotype. We have showed
that such genes do exist. This model should contribute to
the further identification of genes whose modulation may
reduce muscle degeneration in humans. Because of its low
cost, the C. elegans model can also serve to screen for thera-
peutic compounds slowing muscle degeneration. 
Materials and methods
Observation of phenotypes
Photographs of tracks left by worms on the bacterial lawn were taken
by placing regular plates on a Zeiss Stemi dissection microscope at
× 50 magnification. For observation of musculature, phalloidin staining
was performed as in [20] on adult animals. To synchronise animals, L4
larvae grown at 15°C were picked on new plates, and grown 48 h at
15°C before staining. For quantification of body wall muscle structure,
only the centremost 20 cells of the two muscle quadrants facing the
objective were observed (40 cells/animals). Data were compared by a
paired Student’s t-test. Photographs were taken on a Zeiss Axiovert flu-
orescence microscope using a 40 × objective.
Isolation and characterisation of dyc-1
The dyc-1 alleles cx5 and cx32 were obtained by standard EMS muta-
genesis of wild-type N2 animals [28]. The dyc-1 gene was mapped to
the X chromosome and subsequently positioned on the genetic map
between markers unc-9 and unc-3. Injection of cosmid C33G3 fully
rescued dyc-1 alleles. Rescue experiments with portions of C33G3
indicated that dyc-1 corresponds to the predicted gene C33G3.1. The
gene structure and amino-acid sequence of dyc-1 was determined by
sequencing cDNA clone yk259a5, kindly provided by Y. Kohara, NIG,
Japan. The coding sequence was deposited in public databases under
accession number AJ133838. The dyc-1(cx5) mutation introduces a
stop codon at amino-acid position 378; dyc-1(cx32) is a 2 bp inser-
tion, introducing a frame shift after amino acid 279.
Overexpression of DYC-1–GFP and DYC-1
To determine dyc-1 expression, a dyc-1–gfp transgene was con-
structed by inserting a 3.9 kb EcoRV–EcoRV fragment (nucleotides
1–3865 of C33G3) into pPD95.75 (A. Fire), and injected into wild-
type animals at 50 ng/µl, with pRF4 at 100 ng/ml. For rescue experi-
ments, a 11 kb SalI–Bsu36I fragment (encoding amino acids 1–783 of
Dyc-1) was inserted into pPD95.75, and injected at 1 ng/µl, with the
transformation marker KP13 [29] at 100 ng/µl, in dyc-1(cx5) worms.
For overexpression experiments, the same plasmid was injected at
20 ng/µl, with KP13 at 100 ng/µl, in dys-1(cx18); hlh-1(cc561ts)
animals; 3 out of 6 lines obtained showed a consistent reduction of
dys-1(cx18); hlh-1(cc561ts) phenotypes and were kept. Overexpression
of the protein was confirmed by western blot analysis in the three lines.
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